Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Cash from Financing Activities (2023 - 2025)

BrightSpring Health Services' Cash from Financing Activities history spans 3 years, with the latest figure at -$50.5 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 1.91% year-over-year to -$50.5 million; the TTM value through Dec 2025 reached -$157.9 million, down 195.88%, while the annual FY2025 figure was -$157.9 million, 195.88% down from the prior year.
  • Cash from Financing Activities reached -$50.5 million in Q4 2025 per BTSG's latest filing, down from -$13.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $154.8 million in Q1 2024 to a low of -$143.9 million in Q4 2023.
  • Average Cash from Financing Activities over 3 years is -$5.8 million, with a median of -$10.7 million recorded in 2025.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 722.01% in 2024, then tumbled 167.12% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at -$143.9 million in 2023, then skyrocketed by 65.58% to -$49.6 million in 2024, then fell by 1.91% to -$50.5 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Cash from Financing Activities are -$50.5 million (Q4 2025), -$13.1 million (Q3 2025), and -$8.2 million (Q2 2025).